MGC Diagnostics Australia began its operations in the Australasian market in 2006. The company is now considered one of the premier providers of Cardio-Respiratory instrumentation. Our management team embodies over 45 years of global expertise including affiliations with over 50 global healthcare distributors spanning six continents. Our Committment To Our Customers: SERVICE – To set and maintain a new benchmark in Customer Care for Sleep, Rehabilitation & Cardiopulmonary Diagnostics INNOVATION – To bring new and innovative medical devices to Australasia in response to the needs of its Healthcare Community SCIENCE - To advance the level of Science & Technology for diagnostic services CHOICE – To broaden the choice & competition in the Australasian marketplace VALUE – To raise the standard for Quality, Science and Customer Service whilst lowering the ‘total cost-of-ownership’ (TCO) for medical equipment in Australasia. OUR MISSION: To facilitate sustainable and profitable technology transfer between manufacturers and healthcare providers to maximise patient outcomes
Looking for a particular Ascencia employee's phone or email?
The Ascencia annual revenue was $40.5 million in 2026.
Michael Panagopoulos is the Managing Director of Ascencia.
9 people are employed at Ascencia.
Ascencia is based in Dandenong South, Victoria.
The NAICS codes for Ascencia are [33, 339].
The SIC codes for Ascencia are [38, 384].